PortfoliosLab logoPortfoliosLab logo
DCTH vs. ATAI
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

DCTH vs. ATAI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Delcath Systems, Inc. (DCTH) and Atai Life Sciences N.V. (ATAI). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

DCTH vs. ATAI - Yearly Performance Comparison


2026 (YTD)20252024202320222021
DCTH
Delcath Systems, Inc.
-8.12%-16.11%189.42%15.56%-53.55%-23.95%
ATAI
Atai Life Sciences N.V.
-13.45%207.52%-5.67%-46.99%-65.14%-60.77%

Fundamentals

Market Cap

DCTH:

$338.22M

ATAI:

$1.11B

EPS

DCTH:

$0.07

ATAI:

-$2.72

PS Ratio

DCTH:

5.60

ATAI:

210.21

PB Ratio

DCTH:

3.04

ATAI:

5.01

Total Revenue (TTM)

DCTH:

$64.50M

ATAI:

$4.09M

Gross Profit (TTM)

DCTH:

$73.43M

ATAI:

$3.08M

EBITDA (TTM)

DCTH:

$1.61M

ATAI:

-$113.05M

Returns By Period

In the year-to-date period, DCTH achieves a -8.12% return, which is significantly higher than ATAI's -13.45% return.


DCTH

1D
4.39%
1M
4.27%
YTD
-8.12%
6M
-13.67%
1Y
-27.10%
3Y*
17.30%
5Y*
-5.40%
10Y*

ATAI

1D
4.12%
1M
-2.48%
YTD
-13.45%
6M
-33.08%
1Y
160.29%
3Y*
25.06%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DCTH vs. ATAI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DCTH
DCTH Risk / Return Rank: 2424
Overall Rank
DCTH Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
DCTH Sortino Ratio Rank: 2121
Sortino Ratio Rank
DCTH Omega Ratio Rank: 2323
Omega Ratio Rank
DCTH Calmar Ratio Rank: 2424
Calmar Ratio Rank
DCTH Martin Ratio Rank: 2929
Martin Ratio Rank

ATAI
ATAI Risk / Return Rank: 8585
Overall Rank
ATAI Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
ATAI Sortino Ratio Rank: 8888
Sortino Ratio Rank
ATAI Omega Ratio Rank: 8484
Omega Ratio Rank
ATAI Calmar Ratio Rank: 8686
Calmar Ratio Rank
ATAI Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DCTH vs. ATAI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Delcath Systems, Inc. (DCTH) and Atai Life Sciences N.V. (ATAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DCTHATAIDifference

Sharpe ratio

Return per unit of total volatility

-0.47

1.89

-2.36

Sortino ratio

Return per unit of downside risk

-0.39

2.65

-3.04

Omega ratio

Gain probability vs. loss probability

0.95

1.32

-0.37

Calmar ratio

Return relative to maximum drawdown

-0.54

2.93

-3.47

Martin ratio

Return relative to average drawdown

-0.77

5.49

-6.26

DCTH vs. ATAI - Sharpe Ratio Comparison

The current DCTH Sharpe Ratio is -0.47, which is lower than the ATAI Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of DCTH and ATAI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


DCTHATAIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.47

1.89

-2.36

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.07

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.45

-0.36

-0.09

Correlation

The correlation between DCTH and ATAI is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

DCTH vs. ATAI - Dividend Comparison

Neither DCTH nor ATAI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DCTH vs. ATAI - Drawdown Comparison

The maximum DCTH drawdown since its inception was -99.96%, which is greater than ATAI's maximum drawdown of -94.77%. Use the drawdown chart below to compare losses from any high point for DCTH and ATAI.


Loading graphics...

Drawdown Indicators


DCTHATAIDifference

Max Drawdown

Largest peak-to-trough decline

-99.96%

-94.77%

-5.19%

Max Drawdown (1Y)

Largest decline over 1 year

-54.75%

-48.06%

-6.69%

Max Drawdown (5Y)

Largest decline over 5 years

-85.10%

Current Drawdown

Current decline from peak

-99.85%

-82.20%

-17.65%

Average Drawdown

Average peak-to-trough decline

-96.38%

-79.80%

-16.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

38.26%

25.66%

+12.60%

Volatility

DCTH vs. ATAI - Volatility Comparison

The current volatility for Delcath Systems, Inc. (DCTH) is 12.83%, while Atai Life Sciences N.V. (ATAI) has a volatility of 20.69%. This indicates that DCTH experiences smaller price fluctuations and is considered to be less risky than ATAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


DCTHATAIDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.83%

20.69%

-7.86%

Volatility (6M)

Calculated over the trailing 6-month period

36.46%

53.14%

-16.68%

Volatility (1Y)

Calculated over the trailing 1-year period

58.48%

85.60%

-27.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.15%

84.11%

-9.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.20%

84.11%

+27.09%

Financials

DCTH vs. ATAI - Financials Comparison

This section allows you to compare key financial metrics between Delcath Systems, Inc. and Atai Life Sciences N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
1.07M
(DCTH) Total Revenue
(ATAI) Total Revenue
Values in USD except per share items